Neurofilament light protein and glial fibrillary acidic protein as biological markers in MSClas Malmeström, Jan Lycke, Oluf Andersen et al.|Neurology|2003Cited by 318
Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosisMarkus Axelsson, Jan Lycke, Clas Malmeström et al.|Journal of Neurology|2010Cited by 192
Incidence of CSF abnormalities in siblings of multiple sclerosis patients and unrelated controlsSara Haghighi, Staffan Nilsson, Oluf Andersen et al.|Journal of Neurology|2000Cited by 51
Elevated cerebrospinal fluid levels of prostaglandin E2 and 15<i>‐(S)‐</i>hydroxyeicosatetraenoic acid in multiple sclerosisNiklas Mattsson, Domenico Praticò, M. Yaong et al.|Journal of Internal Medicine|2009Cited by 40
Cerebrospinal fluid markers in MS patients and their healthy siblingsSara Haghighi, Lars Rosengren, Oluf Andersen et al.|Acta Neurologica Scandinavica|2003Cited by 40